Inhibrx Biosciences Inc. (INBX)
NASDAQ·Healthcare·Biotechnology
$102.48
-7.39%
Mkt Cap $1.62B
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$325.00
Range $325.00 – $325.00
Implied Upside
+217.1%
Consensus $325.00 vs current $102.48